<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) November 14, 2000
-----------------
Aastrom Biosciences, Inc.
--------------------------------------------------------------------------------
(Exact name of registrant as specified in charter)
Michigan 0-22025 94-3096597
--------------------------------------------------------------------------------
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
24 Frank Lloyd Wright Drive, P.O. Box 376, Ann Arbor Michigan 48106
--------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (734) 930-5555
--------------
Not Applicable
--------------------------------------------------------------------------------
(Former name or former address, if changed since last report)
<PAGE>
Item 7. Financial Statements and Exhibits.
Exhibit
No. Description
--- -----------
99 Slides used in presentations
Item 9. Regulation FD Disclosure.
Attached hereto as Exhibit 99, which is incorporated herein by reference, is a
copy of certain slides used by the Company in making presentations to analysts
and shareholders. This information is not "filed" pursuant to the Securities
Exchange Act and is not incorporated by reference into any Securities Act
registration statements. Additionally, the submission of this report on Form 8-K
is not an admission as to the materiality of any information in this report that
is required to be disclosed solely by Regulation FD.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Aastrom Biosciences, Inc.
Date: November 14, 2000 By: /s/ Todd E. Simpson
----------------------------------------
Vice President, Finance & Administration
and Chief Financial Officer (Principal
Financial and Accounting Officer)
<PAGE>
EXHIBIT INDEX
-------------
Exhibit
No. Description
--- -----------
99 Slides used in presentations
